The University of Chicago Celiac Disease Center has been investigating the mechanisms through which viral infections, in particular gastrointestinal viruses, can contribute to the inflammatory response occurring in celiac disease.
After diagnosis, celiac disease (CD) patients must get regular check ups to see if they are responding to their gluten-free diet. Up to 20% of patients have non-responsive celiac disease (NRCD), typically due to accidental gluten exposure. To see if a patient is recovering from CD the doctor can look for any lessening in symptoms, […]
While the prevalence of celiac disease is estimated to be about 1% in the United States, the number of people who have adopted a gluten-free diet is far greater, as shown by the rapidly expanding gluten-free market. For those people who feel better on a gluten-free diet but have tested negative for celiac disease and […]
Celiac disease, typically thought of as a gastrointestinal disease, has a wide variety of symptoms that can affect other parts of the body including the mind. Many people with celiac disease report having “brain fog”, a form of cognitive impairment that can encompass disorientation, problems with staying focused and paying attention, and lapses in short-term […]
The rate of celiac disease prevalence has been steadily rising. According to a study comparing the stored blood of soldiers with people today, it has increased up to four times within the past 50 years. Looking for the reason behind such a significant rise, many papers have been published investigating possible environmental causes, including one […]
A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at […]
A study recently published by The Journal of the American Medical Association has found further evidence for a link between celiac disease and irritable bowel syndrome (IBS). The study, first posted online on April 21, 2014, titled “Increased Prevalence of Celiac Disease Among Pediatric Patients With Irritable Bowel Syndrome” examined nearly a thousand Italian children […]
Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions . Even patients younger than aged 65 years were at higher risk.
Deborah Ceizler, CDF Chief Development Officer, recently attended the Development of Therapies for Celiac Disease Conference hosted by the Celiac Disease Center at Columbia University. The conference provided a unique opportunity to bring together experts from around the world – physicians, scientists, industry leaders including pharmaceutical, diagnostic, biotechnology and food & agriculture – and patients seeking […]
A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.